(Q65377971)
Statements
CONSCIOUS-3 (English)
0 references
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling. (English)
0 references
1 July 2009
0 references
1 October 2010
0 references
577
0 references
18 year
0 references
75 year
0 references